Similarweb (NYSE:SMWB – Get Free Report) is anticipated to release its Q2 2025 earnings data after the market closes on Tuesday, August 12th. Analysts expect Similarweb to post earnings of ($0.01) per share and revenue of $68.84 million for the quarter. Similarweb has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.
Similarweb (NYSE:SMWB – Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.09). The business had revenue of $67.09 million for the quarter, compared to the consensus estimate of $66.37 million. Similarweb had a negative net margin of 6.97% and a negative return on equity of 71.14%. On average, analysts expect Similarweb to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Similarweb Stock Down 5.8%
Similarweb stock opened at $7.12 on Friday. Similarweb has a 12 month low of $6.36 and a 12 month high of $17.64. The stock has a market cap of $604.44 million, a price-to-earnings ratio of -32.37 and a beta of 1.11. The business has a 50 day moving average price of $8.12 and a two-hundred day moving average price of $9.02.
Analyst Ratings Changes
Check Out Our Latest Research Report on SMWB
About Similarweb
Similarweb Ltd. provides cloud-based digital intelligence solutions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally. The company offers digital research intelligence solutions for its customers to benchmark performance against competitors and market leaders, analyze trends in the market, conduct deeper research into specific companies, and analyze audience behavior; and digital marketing intelligence solutions for its customers to understand their competitors' online acquisition strategies in each marketing channel, and optimize their own strategies.
Featured Stories
- Five stocks we like better than Similarweb
- The Significance of Brokerage Rankings in Stock Selection
- Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?
- How to trade penny stocks: A step-by-step guide
- Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Now Is a Great Time to Buy Cheniere Energy: New High Expected
Receive News & Ratings for Similarweb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Similarweb and related companies with MarketBeat.com's FREE daily email newsletter.